10/19/2022 Categories: Venture Capital Angelini Industries launches Angelini Ventures, with € 300 million commitment
3/22/2022 Categories: Industries Bambino Gesù: the center for pediatric palliative care opens near the sea
6/16/2020 Categories: Industries Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe
Angelini Industries
